What is Catalyst OrthoScience?
Founded in 2014 by orthopedic surgeon Dr. Steven Goldberg, Catalyst OrthoScience is headquartered in Naples, Florida, and is fundamentally redefining the landscape of shoulder replacement surgery. The company distinguishes itself through the development of less invasive surgical techniques that prioritize the preservation of bone and soft tissue. By focusing on precision and efficiency, the firm's total shoulder systems aim to reduce post-operative complications and deliver more natural-feeling outcomes for patients.
The company's market position is bolstered by a growing portfolio of issued and pending patents, which protect its unique technological advancements. Unlike traditional, more invasive surgical approaches, Catalyst OrthoScience provides reproducible results that appeal to both surgeons and healthcare providers seeking to optimize clinical efficiency. As the firm continues to deploy its technology nationwide, it remains a focal point for investors interested in the intersection of medical device innovation and improved patient care.
How much funding has Catalyst OrthoScience raised?
Catalyst OrthoScience has raised a total of $40.2M across 5 funding rounds:
Debt
$350K
Debt
$713K
Other Financing Round
$20M
Private Equity
$4.1M
Debt
$15M
Debt (2020): $350K with participation from PPP
Debt (2021): $713K led by PPP
Other Financing Round (2024): $20M supported by Mutual Capital Partners, RC Capital, and Bridge Bank
Private Equity (2025): $4.1M, investors not publicly disclosed
Debt (2025): $15M backed by Mutual Capital Partners, RC Capital, and Western Alliance Bank
Key Investors in Catalyst OrthoScience
Mutual Capital Partners
Mutual Capital Partners is a Cleveland-based venture capital fund that focuses on investing in early-stage software and medical device companies in the Midwest. The firm partners with innovative healthcare startups, providing not just financial support but also guidance and resources to help them succeed.
RC Capital
RC Capital is a growth equity firm focused on building high-potential healthcare companies by leveraging the interplay of medical devices, healthcare services, and healthcare IT. The firm is dedicated to investing in companies that enhance patient outcomes and improve the delivery of care.
Western Alliance Bank
Western Alliance Bancorporation is a bank holding company whose primary subsidiary, Western Alliance Bank, provides commercial and business banking, treasury management, lending, deposit, mortgage, trust, and digital banking solutions.
What's next for Catalyst OrthoScience?
With the recent influx of capital, Catalyst OrthoScience is poised to enter a new phase of enterprise-level expansion. The strategic focus will likely shift toward scaling manufacturing capabilities, broadening the reach of its sales force, and potentially exploring new indications for its core technology. The involvement of sophisticated growth equity and banking partners suggests a long-term strategy aimed at solidifying the company's leadership in the orthopedic sector.
Looking ahead, the firm is expected to leverage these resources to further validate its clinical outcomes through expanded data collection and physician training programs. By maintaining its commitment to innovation and surgical precision, Catalyst OrthoScience is well-equipped to navigate the complexities of the healthcare market and deliver sustained value to its stakeholders while continuing to improve the quality of life for patients requiring shoulder intervention.
